EpitogenX and Attomarker Sign Strategic Co-Development Agreement to Advance Precision Immunology Diagnostics
EpitogenX and Attomarker sign co-development agreement to advance precision immunology diagnostics in multiple diseases including Lyme Disease and Long Lyme EXETER, UNITED KINGDOM, February 17, 2026 /EINPresswire.com/ -- EpitogenX Ltd and Attomarker Ltd …